Faron Pharmaceuticals said that an abstract highlighting recent data from its phase 3 study of cancer drug, Clevegen, had been selected for a poster discussion...
Resources and energy sector focused Pires Investments said it was planning to enter the technology sector, initially with a £1.1m investment in venture capital fund...
Tekcapital said that 11 companies were now testing a low-sodium salt developed by portfolio company Salarius, for possible incorporation into their snack products.